methoxyhydroxyphenylglycol has been researched along with Agoraphobia in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (82.35) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, JH; Greenblatt, DJ; Jones, KJ; Levine, PH; Orsulak, PJ; Peterson, M; Schildkraut, JJ; Sheehan, DV; Uzogara, E; Watkins, D | 1 |
| Breier, A; Charney, DS; Heninger, GR | 1 |
| Gurguis, GN; Mefford, IN; Uhde, TW | 1 |
| Alling, C; Eriksson, E; Modigh, K; Thuresson, K; Westberg, P | 1 |
| Cook, B; Garvey, M; Noyes, R | 1 |
| Jolkkonen, J; Lepola, U; Riekkinen, P; Rimón, R | 1 |
| Jimerson, DC; Joffe, RT; Post, RM; Uhde, TW | 1 |
| Charney, DS; Heninger, GR | 3 |
| Carr, DB; Coleman, JH; Greenblatt, DJ; Heninger, GR; Jones, KJ; Levine, PH; Sheehan, DV; Surman, OS; Watkins, WD | 1 |
| Cowley, DS; Dager, SR; Dunner, DL | 1 |
| Charney, DS; Gradman, AH; Heninger, GR; McPherson, CA; Woods, SW | 1 |
| Charney, DS; Heninger, GR; Jatlow, PI | 1 |
| Insel, TR; Jimerson, DC; Kafka, M; Kaye, WH; Lake, CR; Murphy, DL; Siever, LJ; Targum, S; Uhde, TW | 1 |
| Lapierre, YD | 1 |
| Davis, CM; Edlund, MJ; Swann, AC | 1 |
1 review(s) available for methoxyhydroxyphenylglycol and Agoraphobia
| Article | Year |
|---|---|
Increased anxiogenic effects of caffeine in panic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Beverages; Blood Pressure; Caffeine; Emotions; Fear; Female; Food; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Placebos; Pulse; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
5 trial(s) available for methoxyhydroxyphenylglycol and Agoraphobia
| Article | Year |
|---|---|
Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; beta-Thromboglobulin; Blood Platelets; Fear; Female; Humans; Ibuprofen; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Panic; Phobic Disorders; Platelet Factor 4; Psychological Tests; Thromboxane B2 | 1984 |
Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; beta-Endorphin; Clinical Trials as Topic; Double-Blind Method; Fear; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Imipramine; Long-Term Care; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Somatostatin | 1989 |
Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
Topics: Adolescent; Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; beta-Endorphin; Endorphins; Epinephrine; Fear; Female; Growth Hormone; Hospitalization; Humans; Infusions, Parenteral; Lactates; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Placebos; Platelet Factor 4; Prolactin; Prostaglandins; Psychiatric Status Rating Scales; Sex Factors | 1986 |
Increased anxiogenic effects of caffeine in panic disorders.
Topics: Adult; Agoraphobia; Anxiety Disorders; Beverages; Blood Pressure; Caffeine; Emotions; Fear; Female; Food; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Placebos; Pulse; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
Topics: Adult; Agoraphobia; Anxiety Disorders; Blood Pressure; Clonidine; Fear; Female; Growth Hormone; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Panic; Placebos; Posture; Receptors, Adrenergic, alpha; Sleep; Sympathetic Nervous System; Yohimbine | 1986 |
12 other study(ies) available for methoxyhydroxyphenylglycol and Agoraphobia
| Article | Year |
|---|---|
Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
Topics: Adult; Aged; Agoraphobia; Anxiety Disorders; Blood Pressure; Fear; Heart Rate; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Pulse; Receptors, Adrenergic; Yohimbine | 1984 |
Hypothalamic-pituitary-adrenocortical activity in panic disorder: relationship to plasma catecholamine metabolites.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Agoraphobia; Catecholamines; Female; Homovanillic Acid; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methoxyhydroxyphenylglycol; Panic Disorder; Pituitary-Adrenal System | 1991 |
Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
Topics: Adult; Agoraphobia; Anxiety Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Panic | 1991 |
Comparison of panic disordered patients with high versus low MHPG.
Topics: Adult; Agoraphobia; Arousal; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged; Panic; Personality Tests | 1990 |
Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
Topics: Adult; Agoraphobia; Depressive Disorder; Fear; Female; Glycols; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methoxyhydroxyphenylglycol; Panic; Phobic Disorders; Pituitary-Adrenal System; Receptors, Adrenergic | 1988 |
Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Blood Pressure; Brain; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Receptors, Adrenergic, alpha; Receptors, GABA-A; Sympathetic Nervous System; Synaptic Transmission; Time Factors; Yohimbine | 1985 |
Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Creatinine; Diazepam; Double-Blind Method; Fear; Humans; Lactates; Lactic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Mitral Valve Prolapse; Panic | 1987 |
Situational panic attacks. Behavioral, physiologic, and biochemical characterization.
Topics: Adult; Agoraphobia; Anxiety Disorders; Blood Pressure; Fear; Female; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Panic; Prolactin; Psychiatric Status Rating Scales; Research Design | 1987 |
Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
Topics: Adult; Agoraphobia; Anxiety Disorders; Blood Pressure; Brain; Female; Humans; Imipramine; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Psychiatric Status Rating Scales; Psychotherapy, Group; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Synaptic Transmission; Time Factors; Yohimbine | 1985 |
Biological alterations in the primary affective disorders and other tricyclic-responsive disorders.
Topics: Adult; Agoraphobia; Anorexia Nervosa; Clonidine; Cyclic AMP; Depressive Disorder; Dihydroergotoxine; Growth Hormone; Humans; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Obsessive-Compulsive Disorder; Panic; Receptors, Adrenergic; Tritium | 1985 |
Clinical and biological correlates of panic states.
Topics: Agoraphobia; Anxiety Disorders; Diagnosis, Differential; Electroencephalography; Evoked Potentials; Fear; Humans; Methoxyhydroxyphenylglycol; Panic; Phobic Disorders; Thyrotropin; Thyrotropin-Releasing Hormone | 1987 |
Plasma MHPG in untreated panic disorder.
Topics: Adult; Agoraphobia; Fear; Female; Glycols; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Phobic Disorders | 1987 |